Technical
Channels

Drug Discovery

Drug Development

Drug Manufacturing

Drug Delivery

Clinical Trials

Regulatory and Legal

Alliances and Mergers

QA/QC and Compliance

Pharmaceutical Processing and Packaging

Change text size [+] [-]

Amsbio: HAMA Blocker for Reduction of Immunoassay Interference

Monday, February 08, 2010
 Email This |  Printer Friendly

Amsbio has introduced TRU Block, a potent reagent that actively blocks the Heterophilic Antibody (HA) interference in immunoassays including but not limited to Human Anti-Mouse Antibody (HAMA) interference.

The reagent offers advantages over traditional Mouse IgG reagents which inhibit HAMA by serving as antigens of HAMA. TRU Block works differently by using a proprietary active mechanism and is 5-20 times more effective than Mouse IgG on HAMA blocking, thereby reducing blocker usage.

Extensive quality control (including a HAMA blocking functional assay, purity and bioburden testing) ensures that every batch of the reagent is well characterized. Guaranteed as greater than 95 percent pure - the purity of the reagent delivers highly consistent performance.


Share this:   Del.icio.us | 
Ask the Expert

What technologies and/or practices can Asian pharma manufacturers adopt today, to ensure quality in their products?

Digital Edition



Singapore's Preclinical R&D industry should differentiate itself in Asia by competing on quality rather than on price.
Yes
No
View results


ABOUT PHARMA ASIA | FREE SUBSCRIPTION | CONTACT US

© 2010 Ten Alps Communications Asia. All rights reserved.
Use of this Web site is subjected to its Terms and Conditions of Use. View our Privacy Policy